Marinus Pharmaceuticals Inc (MRNS)

Marinus Pharmaceuticals Inc Azioni (MRNS) Dati Finanziari

Conto economico

Trimestrale

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	6.80% 7.679	7.19	7.338	6.081	10.38
Operating Expenses	2.05% 43.50	42.63	38.98	37.52	43.34
Interest Income/Expense	1.12% 4.346	4.298	4.242	4.208	4.147
Benefits Costs and Expenses	5.33% 46.35	48.96	40.31	39.55	45.11
Costs And Expenses	2.05% 43.50	42.63	38.98	37.52	43.34
Operating Income/Loss	1.08% -35.82	-35.44	-31.65	-31.44	-32.96
Income/Loss From Continuing Operations Before Tax	7.42% -38.67	-41.77	-32.97	-33.47	-34.73
Income/Loss From Continuing Operations After Tax	7.42% -38.67	-41.77	-32.97	-31.93	-34.73
Net Income/Loss	7.42% -38.67	-41.77	-32.97	-31.93	-34.73
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	5,634% 56.85	0.9914	53.92	52.55	51.77
Diluted Average Shares	5,634% 56.85	0.9914	53.92	52.55	51.77
Basic Earnings Per Share	8.11% -0.68	-0.74	-0.61	-0.61	-0.67
Diluted Earnings Per Share	8.11% -0.68	-0.74	-0.61	-0.61	-0.67
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-